Efficacy And Safety Of An Innovative Treatment Of Opiate Use Disorders

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions

Opioid-use DisorderOpioid DependenceOpioid Abuse

Interventions

DEVICE

supra-luminous LED

810 nm light-emitting diode for the delivery of 2.1 J/cm2 to the brain.

DEVICE

Sham

Light-emitting diode covered with aluminium foil

Trial Locations (2)

McLean Hospital, Belmont

MindLight, LLC, Newton Highlands

All Listed Sponsors

collaborator

Mclean Hospital

OTHER

collaborator

Harvard Medical School (HMS and HSDM)

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

MindLight, LLC

INDUSTRY

NCT04340622 - Efficacy And Safety Of An Innovative Treatment Of Opiate Use Disorders | Biotech Hunter | Biotech Hunter